Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: An 8-year follow-up of the Washington State Diabetes Prediction Study

Diabetes Care

Volumn 25, Issue 3, 2002, Pages 505-511

  LaGasse, James M ^a   Brantley, Michael S ^a   Leech, Nicola J ^b   Rowe, Rachel E ^b   Monks, Stephanie ^c   Palmer, Jerry P ^c   Nepom, Gerald T ^b   McCulloch, David K ^c,d   Hagopian, William A ^a,c  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; INSULIN; INSULIN ANTIBODY; AUTOANTIGEN; IA 2 PROTEIN; IA-2 PROTEIN; MEMBRANE PROTEIN; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; CONFIDENCE INTERVAL; DISEASE COURSE; FOLLOW UP; GENETIC MARKER; GENOTYPE; GLUCOSE TOLERANCE TEST; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PANCREAS ISLET; PREDICTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; UNITED STATES; ADOLESCENT; BLOOD; CAUCASIAN; CHILD; CLINICAL TRIAL; FEMALE; HISPANIC; IMMUNOLOGY; MALE; MULTICENTER STUDY; PREDICTION AND FORECASTING;

ADOLESCENT; AUTOANTIBODIES; AUTOANTIGENS; CHILD; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HISPANIC AMERICANS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MALE; MEMBRANE PROTEINS; PREDICTIVE VALUE OF TESTS; PROTEIN-TYROSINE-PHOSPHATASE; SENSITIVITY AND SPECIFICITY; WASHINGTON;

EID: 0036514136     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.3.505     Document Type: Article

References (46)

1. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type I diabetes: analysis of the data on published incidence trends. Diabetologia 42:1395-1403, 1999
2. Dahlquist GG: Primary and secondary prevention strategies of pre-type 1 diabetes: potentials and pitfalls. Diabetes Care 22 (Suppl. 2):B4-B6, 1999
3. Pugliese A: Unraveling the genetics of insulin-dependent diabetes: the search must go on. Diabetes Reviews 7:39-54, 1999
4. Hagopian W, Sanjeevi C, Kockum I, Landin-Olsson M, Karlsen A, Sundkvist G, Dahlquist G, Palmer J, Lemmark Å: GAD-, insulin- and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
5. Rewers M, Bugawan T, Norris J, Blair A, Beaty B, Hoffman M, McDuffie R Jr, Hamman R, Klingensmith G, Eisenbarth G, Erlich H: Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39:807-812, 1996
6. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
7. Scott-Morgan L, Keller U, Heitz P, Mirza I, Diaz J, Casey C, Wilkin T: Insulin autoantibodies may cause false positive ICA results in the indirect immunofluorescence test. Diabetes Res 8:45-48, 1988
8. Baekkeskov S, Aanstoot H, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
9. Rabin D, Pleasic S, Palmer-Crocker R, Shapiro J: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41:183-186, 1992
10. Rabin D, Pleasic S, Shapiro J, Yoo-Warren H, Oles J, Hicks J, Goldstein D, Rae P: Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 152:3183-3188, 1994
11. Lan M, Lu J, Goto Y, Notkins A: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 13:505-514, 1994
12. Dahlquist G, Blom L, Holmgren G, Hägglōf B, Larsson Y, Sterky G, Wall S: The epidemiology of diabetes in Swedish children 0-14 years old: a 6-year prospective study. Diabetologia 28:802-808, 1985
13. Karjalainen J: Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease. Diabetes 39:1144-1150, 1990
14. Levy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P: Islet cell antibodies in normal French school-children. Diabetologia 35:577-582, 1992
15. Landin-Olsson M, Palmer J, Lernmark Å, Blom L, Sundkvist G, Nystrom L, Dahlquist G: Predictive value of ICA and IAA for IDDM in a population-based study of newly diagnosed diabetic and matched control children. Diabetologia 35:1068-1073, 1992
16. Aanstoot H, Sigurdsson E, Jaffe M, Shi Y, Christgau S, Grobbee D, Bruining G, Molenaar J, Hofman A, Baekkeskov S: Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 37:917-924, 1994
17. Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, Chase P, Klingensmith G, Erlich H, Nords J, Eisenbarth G: Anti-islet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 81:4264-4267, 1996
18. Roll U, Christie M, Fuchtenbusch M, Payton M, Hawkes C, Ziegler A: Perinatal autoimmunity in offspring of diabetic parents: the German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45:967-973, 1996
19. Christie M, Roll U, Payton M, Hatfield E, Ziegler A: Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20:965-970, 1997
20. Bingley P, Bonifacio E, Williams A, Genovese S, Bottazzo G, Gale E: Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710, 1997
21. Rowe R, Leech N, Nepom G, McCulloch D: High genetic risk for IDDM in the Pacific Northwest: first report from the Washington State Diabetes Prediction Study. Diabetes 43:87-94, 1994
22. Schatz D, Krischer J, Home G, Riley W, Spillar R, Silverstein J, Winter W, Muir A, Derovanesian D, Shah S: Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 93:2403-2407, 1994
23. Samuelsson U, Sundkvist G, Borg H, Femlund P, Ludvigsson J: Islet autoantibodies in the prediction of diabetes in school children. Diabetes Res Clin Pract 51:51-57, 2001
24. Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hamalainen A, Korhonen S, Kimpimaki T, Sjoroos M, Ilonen J, Knip M, Simell O: Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 44:290-297, 2001
25. Woo W, LaGasse J, Zhou Z, Patel R, Palmer JP, Campus H, Hagopian WA: A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies. J Immunol Methods 244:91-103, 2000
26. Mire-Sluis A, Das R, Lernmark A: The development of a World Health Organization international standard for islet cell antibodies: the aims and design of an international collaborative study. Diabete Metab Res Rev 15:72-77, 1999
27. Immunology of Diabetes Society: Diabetes Autoantibody Standardization Program. Diabetes Metab Res Rev 17:56, 2001
28. Lernmark Å, Molenaar JL, vanBeers WAM, Yamaguchi Y, Nagataki S, Ludvigsson J, Maclaren NK: The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 34:534-535, 1991
29. Boehm B, Manfras B, Seissler J, Schoffling K, Gluck M, Holzberger G, Seidl S, Kuhnl P, Trucco M, Shcerbaum W: Epidemiology and immunogenetic background of ICA positive non-diabetic schoolchildren. Diabetes 40:1435-1439, 1991
30. Kimura A, Sasazuki T: HLA 1991. In 11th International Histocompatibility Workshop. Tsuji K, Aizawa M, Sasazuki T, Eds. Oxford, U.K., Oxford University Press, 1992, p. 397-419
31. Gambelunghe G, Ghaderi M, Consentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB: Association of MHC class I chain-related A (MIC-A) gene polymorphism with type 1 diabetes. Diabetologia 43:507-514, 2000
32. Kemp EH, Ajjan RA, Waterman EA, Gawkrodger DJ, Cork MJ, Watson PF, Weetman AP: Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo. Br J Dermatol 140:73-78, 1999
33. McIndoe R, Stanford J, Gibbs M, Jarvik G, Brandzel S, Neal C, Li S, Gammack J, Gay A, Goode E, Hood L, Ostrander E: Linkage analysis of 49 high-risk families does not support a common familial prostate cancer susceptibility gene at 1q24-25. Am J Hum Genet 61:347-353, 1997
34. Kahn S, Pridgeon R, McCulloch D, Boyko E, Bergman R, Schwartz M, Neifing J, Ward W, Beard J, Palmer J, Porte DJ: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes 42:1663-1672, 1993
35. Casella G, Berger R: Statistical Inference. Belmont, CA, Duxbury Press, 1990
36. Begg CB, Greenes RA: Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 39:207-215, 1983
37. Dahlquist G, Gustavsson K, Holmgren G, Hagglof B, Larsson Y, Nilsson K, Samuelsson G, Sterky G, Thalme B, Wall S: The incidence of diabetes mellitus in Swedish children 0-14 years of age: a prospective study 1977-1980. Acta Paediatr Scand 71:7-14, 1982
38. Marshall M, Hxyer P, Petersen J, Hejnes K, Genovese S, Dyrberg T, Bottazzo G: Contribution of GAD antibodies to the reactivity of ICA. J Autoimmun 7:497-508, 1994
39. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the IDDM-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
40. Gardner S, Gale E, Williams A, Gillespie K, Lawrence K, Bottazzo G, Bingley P: Progression to diabetes in relatives with islet autoantibodies. Is it inevitable? Diabetes Care 22:2049-2054, 1999
41. Bennett S, Lucassen A, Gough S, Powell E, Undlien D, Pritchard L, Merriman M, Kawaguchi Y, Dronsfield M, Pociot F, et al.: Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene mini-satellite locus. Nat Cenet 9:284-292, 1995
42. Braining G, Grobbee D, Scheffer G, DeBruyn A, Molenaar J, Hofman A, Bruining H, Valkenburg H: Ten-year follow-up study of ICA and childhood diabetes mellitus. Lancet i:1100-1103, 1989
43. Levy-Marchal C, Dubois F, Noel M, Tichet J, Czernichow P: Immunogenetic determinants and prediction of IDDM in French schoolchildren. Diabetes 44:1029-1032, 1995
44. Kulmala P, Rahko J, Savola K, Vahasalo P, Sjoroos M, Reunanen A, Ilonen J, Knip M: Beta-cell autoimmunity, genetic susceptibility, and progression to diabetes in unaffected schoolchildren. Diabetes Care 24:171-173, 2001
45. Schwartz R. The new immunology: the end of immunosupressive drug therapy. N Engl J Med 340:1754-1756, 1999
46. Williams A, Bingley P, Bonifacio E, Palmer J, Gale E: A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473-478, 1997